Drug Profile

Minoxidil foam formulation - 3SBio

Alternative Names: MN-709

Latest Information Update: 02 Jun 2022

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator 3SBio
Class Antihypertensives; Peripheral vasodilators; Piperidines; Skin disorder therapies; Small molecules
Mechanism of Action Undefined mechanism

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

31 Dec 2021 Preregistration for Alopecia in China (Topical)
30 Mar 2021 3SBio completes enrolment in its phase III trial for Alopecia in China
23 Apr 2020 Phase-III clinical trials in Alopecia (Topical), prior to April 2020 (3SBio pipeline, April 2020)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com